 | Regular Links |
Pharmaffiliates Analytics & Synthetics (P) Ltd
Pharmaffiliates Analytics & Synthetics (P) Ltd, is an integrated Contract Research Organisation (CRO) services provider offering its expertise in Custom synthesis (Reference standards, Impurities, Metabolites, Deuterated compounds and Phyto standards), Analytical research (PH Buffer Solutions, Method development, Validation), Stability studies, Formulation & Development (New Drug Delivery System), Quality assurance and Regulatory services with a right blend of competent people, state of the art infrastructure facilities, cutting-edge technology and certified processes to pump your development pipeline with time and cost advantages. Our expertise will also enable you to combat in the highly competitive markets and also in acquiring the niche segments. We desire to be your strategic partner for outsourcing and help you right from strategic planning of CMC blue-print to accelerating the filing and representation for NDAs and ANDAs submitted in any regulated and semi-regulated markets which can reduce your time and efforts for focusing them in your core areas of operations.
Since its inception in 2001, Pharmaffiliates has been serving customers across the globe comprising major Pharmaceutical companies, API manufacturers, Bulk drug suppliers, clinical CROs and other allied industries. Our effectiveness in successful service delivery has had its origin in our endeavor to carry out projects efficiently, on time and at a reasonable cost. We are dedicated to cultivate and house the highest quality scientific base with which we strive to meet the needs of our clients, who made us the first Indian company to provide third party audits in India and neighbouring countries on behalf of the European manufacturers in accordance with the EMEA requirements. [Details]
http://pharmaffiliates.com |
Robb Wolf
On the other hand, our company have outstanding records off PREDIMED that higher nut intake stops stroke; on top of that, there are actually 5 or even 6 observational research studies advising affiliations along with lower prices from quick heart death and also coronary vein endpoints (e.g.
myocardial infarction). [Details]
http://www.iamsport.org/pg/pages/view/32250695/ |
|
